STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $51,000 | -61.1% | 10,612 | -13.9% | 0.00% | – |
Q4 2019 | $131,000 | 0.0% | 12,328 | -1.9% | 0.00% | – |
Q3 2019 | $131,000 | -24.3% | 12,571 | +16.4% | 0.00% | – |
Q2 2018 | $173,000 | +7.5% | 10,803 | +2.7% | 0.00% | – |
Q1 2018 | $161,000 | -4.7% | 10,523 | -3.0% | 0.00% | – |
Q4 2017 | $169,000 | -29.0% | 10,846 | -34.1% | 0.00% | – |
Q1 2015 | $238,000 | -13.8% | 16,457 | +1.9% | 0.00% | -100.0% |
Q4 2014 | $276,000 | – | 16,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |